Bio-Gene Technology Ltd (BGT) — Free Cash Flow Generation Index

Latest as of June 2022: 0.84x

Bio-Gene Technology Ltd (BGT) has a Free Cash Flow Generation Index of 0.84x as of June 2022. Free cash flow of AU$36.67K represents 1% of operating cash flow (AU$43.52K). Explore Bio-Gene Technology Ltd (BGT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.84x

Free Cash Flow / Operating CF

Free Cash Flow

AU$36.67K

AUD

Operating Cash Flow

AU$43.52K

AUD

Capital Expenditures

AU$6.84K

AUD

Bio-Gene Technology Ltd Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Bio-Gene Technology Ltd across 1 annual periods. For the full cash flow conversion analysis, see Bio-Gene Technology Ltd (BGT) cash flow conversion.

Annual Free Cash Flow Generation for Bio-Gene Technology Ltd (2022–2022)

Year-by-year Free Cash Flow Generation Index for Bio-Gene Technology Ltd. Check cash flow reinvestment rate of Bio-Gene Technology Ltd to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (AUD)	Operating CF	Capital Expenditures	YoY Change
2022	0.84x	AU$36.67K	AU$43.52K	AU$6.84K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).